1Vaccine Research Department, FISABIO, Valencia, Spain
2Centro de Investigación Biomédica en Red de Epidemiologia y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain
3Futurenest Clin. Res. Ltd, Miskolc, Hungary
4Department of Health Sciences, University of Genoa-Hygiene Unit, San Martino Policlinico Hospital, Genoa, Italy
5Department of Paediatrics, KTP-National University Children’s Medical Institute, National University Hospital, Singapore, Singapore
6Isabelle Betrand-Gerentes, Global Medical, Sanofi Vaccines, 14 Espa. Henry Vallée, 69007 Lyon, France
7Patient Safety and Pharmacovigilance, Sanofi R&D, Cambridge, USA
8Global Biostatistical Sciences, Sanofi Vaccines, Marcy L’Étoile, France
© The Author(s) 2025
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
